In the EFFISAYIL Phase II global clinical trial, patients experiencing a GPP flare were treated with Spesolimab or Placebo. (Image Credits: Pixabay) The Central Drugs Standard Control Organisation ...
Boehringer Ingelheim gets CDSCO nod for drug to treat GPP The approval of SPEVIGO by the CDSCO represents a significant milestone in GPP management in India and underscores our commitment to bringing ...
The Central Drugs Standard Control Organisation (CDSCO) in India has approved Boehringer Ingelheim’s Spevigo (spesolimab) injection, a first-in-class treatment for generalized pustular psoriasis (GPP) ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended to the drug regulator to grant permission to Boehringer Ingelheim India for import and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results